Search

everythinglearnresearchcommunity

for

Search:↓

CD117 and platelet-derived growth factor receptor α may play a role in alopecia areata.

Alopecia Areata is linked to a higher risk of several diseases, which vary with age and sex.

A woman's hair grew back after stopping acitretin for psoriasis and getting steroid treatment, and low vitamin D might be linked to alopecia severity.

A mix of methotrexate, corticosteroids, and topical minoxidil effectively treated severe total body hair loss, but caused stretch marks and needs long-term monitoring.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Intravenous corticosteroid therapy is effective for long-term hair regrowth in alopecia areata, and a scoring system helps predict treatment success and relapse.

Combining TRA and latanoprost is most effective for treating localized alopecia areata.

Experts recommend personalized treatment plans for best outcomes in managing Alopecia Areata.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

PRP is an effective and safe treatment for alopecia areata.

Fzd2 is important for skin and hair development through various signaling ways.

Upadacitinib may effectively treat alopecia areata without side effects.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Machine learning can accurately identify Alopecia Areata, aiding in early detection and treatment of this hair loss condition.

Too much epidermal growth factor can cause hair loss.

New understanding and treatments for hair loss are improving, but more research is needed.

PRP is an effective and safe treatment for hair loss in women.

People with severe hair loss have lower zinc levels in their blood.

There have been major advances in diagnosing and treating hair loss over the last 30 years, with new drugs and improved hair transplant techniques.

Trichoscopy is a quick, accurate, and non-invasive method to diagnose and treat non-scarring hair loss.

Vitamin D deficiency is common in people with certain types of hair loss, like alopecia areata and female pattern hair loss.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Dupilumab for skin problems might reactivate hair loss in some patients.

The MPV/PC ratio can help assess disease activity in alopecia areata.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.